This inventor holds 1 USPTO granted patent. Top assignee: Blue Heron Biotechnology, Inc.. Active years: 2007.
Company Filing History:
Years Active: 2007
Title: R Gregg Brickner: Innovator in Polynucleotide Synthesis
Introduction
R Gregg Brickner is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of biotechnology, particularly in the area of automated polynucleotide synthesis. His innovative work has led to the development of a unique system that enhances the efficiency of synthesizing polynucleotides.
Latest Patents
R Gregg Brickner holds a patent for a "Method and system for polynucleotide synthesis." This patent describes methods and systems for automated polynucleotide synthesis design. The Automated Polynucleotide Synthesis Design System (APSDS) is a key feature of this invention. It automatically generates a synthesis design for a designated target sequence specification. The APSDS includes a synthesis design engine, user interface support, a synthesis rules data repository, and a synthesis data repository. The system evaluates potential designs against synthesis rules and adjusts them as necessary until a successful design is achieved or no solution is found.
Career Highlights
R Gregg Brickner is associated with Blue Heron Biotechnology, Inc., where he applies his expertise in biotechnology and innovation. His work at the company has been instrumental in advancing the capabilities of polynucleotide synthesis.
Collaborations
Some of his notable coworkers include John Thomas Mulligan and John C Tabone. Their collaboration has contributed to the innovative environment at Blue Heron Biotechnology, Inc.
Conclusion
R Gregg Brickner's contributions to the field of biotechnology, particularly through his patent on automated polynucleotide synthesis, highlight his role as an innovator. His work continues to influence advancements in the synthesis of polynucleotides, showcasing the importance of innovation in scientific research.